Human Umbilical Cord Mesenchymal Stem Cell Therapy for Cerebral Infarction Patients in Convalescent Period.

Not yet recruiting

Phase 1/2 Results N/A

Summary of Purpose

This is a randomized, double-blind study. Human umbilical cord mesenchymal stem cells (hUC-MSC) will be treated on cerebral infarction patients, and evaluates their neurological function of convalescent period.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 6 June 2017.

1 Jul 2017 23 May 2017 1 Feb 2018 1 Aug 2018 1 Jun 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts